NEW YORK — The director of the Food and Drug Administration's Office of Generic Drugs is stepping down, according to published reports.
Pharmalot, a blog run by journalist Ed Silverman, reported that Greg Geba is leaving the office over differences resulting from a recent reorganization, effective Friday.